Cargando…

Peer review of the pesticide risk assessment of the active substance Beauveria bassiana strain 203

The conclusions of EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State the Netherlands for the pesticide active substance Beauveria bassiana strain 203 are reported. The context of the peer review was that required by R...

Descripción completa

Detalles Bibliográficos
Autores principales: Anastassiadou, Maria, Arena, Maria, Auteri, Domenica, Brancato, Alba, Bura, Laszlo, Carrasco Cabrera, Luis, Chaideftou, Eugenia, Chiusolo, Arianna, Crivellente, Federica, De Lentdecker, Chloe, Egsmose, Mark, Fait, Gabriella, Greco, Luna, Ippolito, Alessio, Istace, Frederique, Jarrah, Samira, Kardassi, Dimitra, Leuschner, Renata, Lostia, Alfonso, Lythgo, Christopher, Magrans, Oriol, Mangas, Iris, Miron, Ileana, Molnar, Tunde, Padovani, Laura, Parra Morte, Juan Manuel, Pedersen, Ragnor, Reich, Hermine, Santos, Miguel, Sharp, Rachel, Szentes, Csaba, Terron, Andrea, Tiramani, Manuela, Vagenende, Benedicte, Villamar‐Bouza, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659519/
https://www.ncbi.nlm.nih.gov/pubmed/33209153
http://dx.doi.org/10.2903/j.efsa.2020.6295
Descripción
Sumario:The conclusions of EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State the Netherlands for the pesticide active substance Beauveria bassiana strain 203 are reported. The context of the peer review was that required by Regulation (EC) No 1107/2009 of the European Parliament and of the Council. The conclusions were reached on the basis of the evaluation of the representative uses of Beauveria bassiana strain 203 as an insecticide on Phoenix canariensis (field use, indoor and greenhouse applications) and Phoenix dactylifera (field use) in southern Europe. The reliable endpoints, appropriate for use in regulatory risk assessment, are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are identified.